- Home
- ACRV vs FTHM Comparison
ACRV vs FTHM Comparison
Compare ACRV & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- FTHM
- Stock Information
- Founded
- ACRV 2018
- FTHM 2010
- Country
- ACRV United States
- FTHM United States
- Employees
- ACRV N/A
- FTHM N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- FTHM Real Estate
- Sector
- ACRV Health Care
- FTHM Finance
- Exchange
- ACRV Nasdaq
- FTHM Nasdaq
- Market Cap
- ACRV 47.8M
- FTHM 54.7M
- IPO Year
- ACRV 2022
- FTHM 2020
- Fundamental
- Price
- ACRV $1.87
- FTHM $1.25
- Analyst Decision
- ACRV Buy
- FTHM Strong Buy
- Analyst Count
- ACRV 6
- FTHM 1
- Target Price
- ACRV $17.75
- FTHM $2.50
- AVG Volume (30 Days)
- ACRV 1.1M
- FTHM 213.2K
- Earning Date
- ACRV 11-07-2025
- FTHM 11-11-2025
- Dividend Yield
- ACRV N/A
- FTHM N/A
- EPS Growth
- ACRV N/A
- FTHM N/A
- EPS
- ACRV N/A
- FTHM N/A
- Revenue
- ACRV N/A
- FTHM $390,032,000.00
- Revenue This Year
- ACRV N/A
- FTHM $25.22
- Revenue Next Year
- ACRV $805.34
- FTHM $16.19
- P/E Ratio
- ACRV N/A
- FTHM N/A
- Revenue Growth
- ACRV N/A
- FTHM 19.16
- 52 Week Low
- ACRV $1.05
- FTHM $0.65
- 52 Week High
- ACRV $8.74
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- ACRV 48.13
- FTHM 34.87
- Support Level
- ACRV $1.91
- FTHM $1.54
- Resistance Level
- ACRV $2.46
- FTHM $1.84
- Average True Range (ATR)
- ACRV 0.17
- FTHM 0.13
- MACD
- ACRV -0.02
- FTHM -0.03
- Stochastic Oscillator
- ACRV 15.69
- FTHM 15.94
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.